BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29191590)

  • 1. Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry.
    Lara JD; Brunson A; Riess JW; Kelly K; Lara PN; Gandara DR
    Lung Cancer; 2017 Oct; 112():165-168. PubMed ID: 29191590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis.
    Lara MS; Brunson A; Wun T; Tomlinson B; Qi L; Cress R; Gandara DR; Kelly K
    Lung Cancer; 2014 Aug; 85(2):264-9. PubMed ID: 24878033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of histological subtype and treatment modalities on T1-2 N0-1 small cell lung cancer: A population-based study.
    Moon SW; Seo JH; Jeon HW; Moon MH
    Thorac Cancer; 2019 May; 10(5):1229-1240. PubMed ID: 30993901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
    Xu L; Zhang G; Song S; Zheng Z
    Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
    Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
    Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
    Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
    BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
    Ou SH; Ziogas A; Zell JA
    J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Race, Socioeconomic Factors, and Treatment Characteristics With Overall Survival in Patients With Limited-Stage Small Cell Lung Cancer.
    Zhou K; Shi H; Chen R; Cochuyt JJ; Hodge DO; Manochakian R; Zhao Y; Ailawadhi S; Lou Y
    JAMA Netw Open; 2021 Jan; 4(1):e2032276. PubMed ID: 33433596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.
    Aarts MJ; Aerts JG; van den Borne BE; Biesma B; Lemmens VE; Kloover JS
    Clin Lung Cancer; 2015 Jul; 16(4):282-91. PubMed ID: 25572007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
    Ignatius Ou SH; Zell JA
    J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.
    Shojaee S; Singh I; Solsky I; Nana-Sinkam P
    Respiration; 2019; 98(3):198-202. PubMed ID: 31121583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.
    Liu S; Guo H; Kong L; Li H; Zhang Y; Zhu H; Yu J
    Int J Clin Exp Pathol; 2015; 8(9):11033-41. PubMed ID: 26617821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better cancer specific survival in young small cell lung cancer patients especially with AJCC stage III.
    Wang H; Zhang J; Shi F; Zhang C; Jiao Q; Zhu H
    Oncotarget; 2017 May; 8(21):34923-34934. PubMed ID: 28432275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study.
    Tendler S; Holmqvist M; Wagenius G; Lewensohn R; Lambe M; De Petris L
    Lung Cancer; 2020 Jan; 139():111-117. PubMed ID: 31760352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
    Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
    Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients.
    Chen J; Jiang R; Garces YI; Jatoi A; Stoddard SM; Sun Z; Marks RS; Liu Y; Yang P
    Lung Cancer; 2010 Feb; 67(2):221-6. PubMed ID: 19497635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of prophylactic cranial irradiation in limited-stage small-cell lung cancer: which patients could benefit?
    Kou P; Wang H; Yang D; Zhang Y; Yu J
    Future Oncol; 2019 Jan; 15(1):3237-3245. PubMed ID: 30091368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
    Abdel-Rahman O
    Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry.
    Hong JC; Boyer MJ; Spiegel DY; Williams CD; Tong BC; Shofer SL; Moravan MJ; Kelley MJ; Salama JK
    J Natl Compr Canc Netw; 2019 Feb; 17(2):127-139. PubMed ID: 30787126
    [No Abstract]   [Full Text] [Related]  

  • 20. Temporal trends from 1986 to 2008 in overall survival of small cell lung cancer patients.
    Schabath MB; Nguyen A; Wilson P; Sommerer KR; Thompson ZJ; Chiappori AA
    Lung Cancer; 2014 Oct; 86(1):14-21. PubMed ID: 25115410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.